{"name":"Mark Walters, MD","slug":"mark-walters-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPNExjZjIwMUMyZVNuN1l2ZDJyTlN0UC12Rm02NFpRREZ4azVoWWFMeTFVemVIQmh2cDlUMHhFSXRrTHAyZkpzLXJrT2g0NXM5NGk1S1hlYWo0MWpQNzdSdzJObnNobXUzS19KbUp3bmp4d1NDQ3EwRXlQQlRpSkVlSGMycE14XzV1YlBXMUo3OHpILUMwRS1RSUQ3RnkyVVZfdi0yMnBERWdPUHZwb0ZRaGV1dGFDb1k?oc=5","date":"2024-09-27","type":"regulatory","source":"CGTLive®","summary":"Canada Approves Vertex and CRISPR Therapeutics’ Gene Therapy Casgevy for Sickle Cell Disease and TDT - CGTLive®","headline":"Canada Approves Vertex and CRISPR Therapeutics’ Gene Therapy Casgevy for Sickle Cell Disease and TDT - CGTLive®","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1XTHo4R0c3T2FEcXFnRzFaeHR2QXdCa1R1VDZyR0ROdkVOSzRUVlNxSDBhVmFXQldnXzhRSmZSRjF2VnFnLUh6b0RyTkpkdG1WSXBMZmpvTFR2TmlZckxCQ3FwRVEwbm1pbGhFWTQ2d3d5Uzg3eW9XRlRR?oc=5","date":"2024-08-27","type":"pipeline","source":"CGTLive®","summary":"The Future of Sickle Cell Disease’s Landscape of Care - CGTLive®","headline":"The Future of Sickle Cell Disease’s Landscape of Care - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQTC10VEJWVE4tZEdwMGx3aXdCTm5lekdSSFVHTmVKMy1fQ0hFQUJqNTRMR3hfV3lRRWtqVnZrUmZsNFRYcEJOOHFXVGJsTzN0eDQyWVhfLUVyYTVsd0xYbEt3QnBLVDBBYTM1bHV0MnZSSzh2dUZmVXBtWS1wcmFWYkNaSHBiMXlmalZxOG1PVEQ?oc=5","date":"2024-02-28","type":"pipeline","source":"CGTLive®","summary":"Mark Walters, MD, on Lessons Learned With Investigating Lovo-Cel for Sickle Cell - CGTLive®","headline":"Mark Walters, MD, on Lessons Learned With Investigating Lovo-Cel for Sickle Cell - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5ESWtkcDY2LUlmaVRhRkN4UHBSMmZkNTN2M2hJdlItS1pVVlZRc3BoalVIVTVxNWNkT01LTmJYQTBwSTdPQlA0OWJ5cW1wZG04cFZ4b0VQY3F2alZuTHBuTFhOYjB6T1pC?oc=5","date":"2023-12-15","type":"trial","source":"Wiley Online Library","summary":"Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing - Wiley Online Library","headline":"Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBhNHZVczRfaHJ4bndTalpBeW1lVm5SVjJSdVUzSU1zMVo2NVZPRkVkZEhNQ0RMeUtzSVlfQUxUMDlncVdEU1lCc0lSSkxtU0Nzd3FqTDF4ZG9RZEozdkFqOFdHdmNMMUQ0?oc=5","date":"2023-11-27","type":"trial","source":"Wiley Online Library","summary":"Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing - Wiley Online Library","headline":"Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPLWVtNXlxREdRaHdZVVcyTFdZN2VXRFNpdUhyY1oydXpUSHFHbmxDZDdjOWZBMkFHUFhqQ1hUYkNydGhtRnJlYlFFbDBaRjVCQzBDeEVLNEdPZmJQbm5TSUNjMUVyRU1vZnpFT29zVVBiWFdoazR5MHJKSnNibElJSUw2NV9tSWRjZzhUclVsRlVleFFHQkN0WWtpTXR3Z1ZoS1c1WHA1VWlCNm5hQUxWY0t3TGRpelU4S3UtTUR2X21xZjY4ZjRDZWdLT0lGLU0?oc=5","date":"2022-04-14","type":"pipeline","source":"Healio","summary":"UCSF researchers hope to cure sickle cell disease through CRISPR gene editing - Healio","headline":"UCSF researchers hope to cure sickle cell disease through CRISPR gene editing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1VRDJWWTJUQno3TW11cmlkTnc1cTJqSVZCRGJySFJYUE5jeFg4SGxJbDdhS0laSjRMRkFzZDZJM0gycHVtYVNGeHlLWHlwOUNBU1lDLXd3aDM3ZjJzdVRUXw?oc=5","date":"2018-04-18","type":"pipeline","source":"NEJM","summary":"Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia - NEJM","headline":"Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNSHBvck1Xa1dBNVpCUFp6SWtDX1pBSjNPNGQ3enlObVhtbHVMbE1paG45X0RUc1JuNVZFUnVDUXJhZVBSVUc5VThaV21PMWZQUjhQS01UcHpfWk8xYU02aHJJNC1zd3lod2h2dkVJMWtSMUpUVS1faW15Z1p1RjBpTHJaekh3NXJSbWtIMDlxUDczTG5uRzdRaEYwM3FBaUROVk43eTRMTGtaTUVBTXFQQXIzVk9KTHBtdHVzNmZZaEJuNWZxWFVOSk1VLWlNN0pKR1BZ?oc=5","date":"2015-12-12","type":"trial","source":"European Medical Journal","summary":"Northstar study: gene therapy for beta-thalassemia major using LentiGlobin BB305 drug product - European Medical Journal","headline":"Northstar study: gene therapy for beta-thalassemia major using LentiGlobin BB305 drug product","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}